I-MOVE+ awarded with a “Stars of Europe” Trophy
The I-MOVE+ project, coordinated by Epiconcept, was honored at the seventh edition of the “Stars of Europe” ceremony which rewards research teams’ commitment to European projects. The ceremony took place on December 10, 2019 at the Musée du Quai Branly in Paris, at the end of the Horizon 2020 Forum.
I-MOVE+: Measuring and comparing the effectiveness and impact of influenza and pneumococcal vaccines
I-MOVE+ (Integrated Monitoring of Vaccines in Europe) is a consortium of 29 partners (regional and national public health institutes, SME, Universities) from 16 European Union / European Economic Area Member States. Its goal is to develop a sustainable platform of primary care, hospital and laboratory networks that use validated standardised methods to evaluate existing and new vaccine programmes independently from commercial interests.
In the case of influenza, the project developed a network of multicentre vaccine studies involving more than 15,000 patients per season from 14 countries and large digital data sets from 5 countries. In the case of pneumococcal infections, the network has set up multicentre studies based on enhanced surveillance in the elderly and has achieved significant results for the target age group (65+ years).
Through common study protocols and monitoring strategies, I-MOVE+ successfully answered research questions that could not be studied by individual countries due to the limited sample size of the study.
The Stars of Europe in detail
Created in 2013 at the initiative of the Ministry of Higher Education and Research launched in 2013, the Stars of Europe aim to promote research teams (coordinated by a project leader registered on behalf of a French structure) for their European commitment and their project coordination work. Each year, winning projects (11 this year) are selected according to the following criteria: scientific quality and international dimension of projects, value creation (economic and technological spin-offs), societal, multidisciplinary and inclusive dimension of the project, in particular for women and young researchers, strategic dimension (French influence on the international scene, accessibility of results, regional development).